Skip to content

Vibrating socks for Parkinson’s Disease

Vibrating socks: a novel cueing intervention to reduce freezing of gait in Parkinson’s disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23820
Enrollment
40
Registered
2019-04-17
Start date
2020-02-14
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Vibrating socks, a new tactile cueing device

Sponsors

Medisch Spectrum Twente
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Idiopathic Parkinson’s disease. Recent history of disabling/regular freezing of gait (defined as presence of FOG several times a day in the past month and lasting longer than 1 second and verified objectively by an experienced neurologist).

Exclusion criteria

Exclusion criteria: Gait impairments as a result of any other factor than Parkinson’s disease. Sensory impairments (e.g. due to polyneuropathy) hampering patients to perceive vibration of the socks. Cognitive impairments that causes the patient to be unable to understand the research purpose and accompanying instructions.

Design outcomes

Primary

MeasureTime frame
The presence and percent time of FOG (total FOG duration divided by the total walking duration). The presence and percent time of FOG will be determined via offline visual analysis of the videos by experienced raters.

Secondary

MeasureTime frame
Spatiotemporal gait parameters as obtained by instrumented gait analysis (Xsense), including velocity, step length, cadence and relative durations of the single and double limb support phases). In addition, patients’ experience will be evaluated using standardized questionnaires.

Contacts

Public ContactMarleen C. Tjepkema-Cloostermans

Medisch Spectrum Twente

m.tjepkema-cloostermans@mst.nl+31 53 487 2850

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)